Thousands are living with Parkinson's undiagnosed and unsupported, our new research finds
Date
Research news
Date
An app for people with Parkinson’s to remotely monitor and manage their non-motor symptoms is now entering the testing phase.
Date
Treatments targeting a protein called LRRK2 are currently being tested in clinical trials for Parkinson's. Researchers hope they may have the ability to slow the progression of the condition which is something no current treatment can do.
Date
Researchers at Queen Mary University of London have reported results from the first UK study of the early signs of Parkinson's in a highly diverse population.
Date
Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.
Date
Researchers, including scientists from Queen's University Belfast, have discovered that people with Parkinson's who eat more flavonoids may have a longer life expectancy.
Date
Researchers in the Netherlands discover that regular exercise may improve Parkinson’s symptoms by creating connections between areas of the brain affected by the condition.
Date
If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Date
Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
Date
The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.
Date
UCB, a global pharmaceutical company, has joined forces with Parkinson's UK, and the Parkinson's Foundation in the US, to establish a Patient Engagement Council for Parkinson's Research.